知名学者引用


        除了所发表论文的被引用频次、期刊质量能够彰显学者的学术影响力以外,被知名学者引用也是一项学术评价的重要指标。
        当前全球学者库认定的知名学者包括:诺贝尔奖、菲尔兹奖、图灵奖等奖项获得者,多个国家的院士,全球学者库“2023全球学者学术影响力排行版”入榜的前10万学者等。

Shi, Jinghan 同济大学被知名学者引用:18人次(黄金会员以上可以申请导出本人论文被全部知名学者引用的数据)

1. Fernando D,Martinez 美国 University of Arizona Single-Cell Profiling of Premature Neonate Airways Reveals a Continuum of Myeloid Differentiation

2. Jin Mo,Goo 韩国 Seoul National University Diagnostic performance and prognostic value of CT-defined visceral pleural invasion in early-stage l..

3. Genichiro,Ishii 日本 National Cancer Center Hospital East Efficacy of Preoperative Biopsy in Predicting the Newly Proposed Histologic Grade of Resected Lung A..

4. 杜永忠 中国 浙江大学 教授,博士生导师 Preventing acute lung injury from progressing to pulmonary fibrosis by maintaining ERS homeostasis t..

5. Lin, Steven Hsesheng 美国 University of Texas MD Anderson Cancer Center Gene expression profiling of circulating tumor cells captured by MicroCavity Array is superior to en..

6. James M,Reuben 美国 University of Texas MD Anderson Cancer Center Gene expression profiling of circulating tumor cells captured by MicroCavity Array is superior to en..

7. 徐世文 中国 东北农业大学 教授 博士生导师 Selenium Deficiency Aggravates Heat Stress Pneumonia in Chickens by Disrupting the M1/M2 Balance

8. 陈海泉 中国 复旦大学上海医学院 主任医师 Comprehensive analysis of mutational profile and prognostic significance of complex glandular patter..

9. Ross A,Soo 新加坡 National University Health System Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-sma..

10. Eng-Huat,Tan 新加坡 National Cancer Center Singapore Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-sma..

11. Sai-Hong Ignatius,Ou 美国 University of California-Irvine Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-sma..

12. Dong-Wan,Kim 韩国 Seoul National University Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-sma..

13. Geoffrey,Liu 加拿大 University of Toronto Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-sma..

14. Benjamin J,Solomon 澳大利亚 Peter MacCallum Cancer Center Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-sma..

15. Kazuo,Awai 日本 Hiroshima University Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-pos..

16. Mauro,Piacentini 意大利 University of Roma Tor Vergata Analysis of Secreted Proteins from Prepubertal Ovarian Tissues Exposed In Vitro to Cisplatin and LH

17. Claudio,Sette 意大利 University of Cattolica Sacro Cuore Analysis of Secreted Proteins from Prepubertal Ovarian Tissues Exposed In Vitro to Cisplatin and LH

18. Carmen,Garrido 法国 INSERM The HSP GRP94 interacts with macrophage intracellular complement C3 and impacts M2 profile during ER..

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3